HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Wyndham H Wilson Selected Research

Wyndham H Wilson Research Topics

Disease

24Neoplasms (Cancer)
09/2014 - 06/2002
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
05/2015 - 06/2002
15Lymphoma (Lymphomas)
09/2015 - 02/2002
11B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2013 - 09/2002
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 09/2005
7B-Cell Lymphoma (Lymphoma, B Cell)
11/2013 - 02/2002
5Burkitt Lymphoma (Burkitt's Lymphoma)
07/2014 - 06/2006
5Infection
08/2013 - 12/2004
4Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2014 - 08/2005
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2014 - 11/2004
4Hairy Cell Leukemia
05/2012 - 11/2004
4Hemolytic-Uremic Syndrome
05/2012 - 09/2005
4Acquired Immunodeficiency Syndrome (AIDS)
03/2012 - 06/2003
4Neutropenia
01/2011 - 08/2005
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2010 - 02/2006
3AIDS-Related Lymphoma (Lymphoma, AIDS Related)
11/2014 - 04/2006
3Leukemia
05/2012 - 09/2009
3T-Cell Lymphoma (Lymphoma, T Cell)
02/2011 - 07/2007
2Disease Progression
05/2015 - 05/2012
2Hematologic Neoplasms (Hematological Malignancy)
09/2014 - 06/2011
2Thrombocytopenia (Thrombopenia)
12/2010 - 09/2002
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2010 - 02/2006
2Pneumonia (Pneumonitis)
05/2010 - 12/2004
2Opportunistic Infections (Opportunistic Infection)
04/2010 - 07/2006
1Ataxia (Dyssynergia)
11/2013
1Immune System Diseases (Immune Disorders)
08/2013
1Hemolysis
08/2013
1Hodgkin Disease (Hodgkin's Disease)
02/2013
1Sclerosis
02/2013
1Lymphocytosis
12/2011
1Circulating Neoplastic Cells
12/2011
1Inflammation
01/2011
1Bronchitis
12/2010
1Pleural Effusion (Pleural Effusions)
12/2010
1Hemorrhage
12/2010
1Cardiac Arrhythmias (Arrythmia)
12/2010
1Multiple Myeloma
10/2010
1Arthritis (Polyarthritis)
10/2010
1Plasmacytoma
10/2010

Drug/Important Bio-Agent (IBA)

21rituximab (Mabthera)FDA Link
11/2014 - 02/2002
12Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014 - 02/2002
12Vincristine (Oncovin)FDA LinkGeneric
11/2014 - 02/2002
12Prednisone (Sone)FDA LinkGeneric
11/2014 - 02/2002
11Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014 - 02/2002
11Etoposide (VP 16)FDA LinkGeneric
11/2013 - 02/2002
6Cyclin D1IBA
11/2013 - 02/2003
4bortezomib (Velcade)FDA Link
09/2015 - 06/2009
4Biological Markers (Surrogate Marker)IBA
09/2014 - 06/2008
4anaplastic lymphoma kinaseIBA
08/2014 - 11/2004
3DNA (Deoxyribonucleic Acid)IBA
09/2015 - 06/2002
3Immunotoxins (Immunotoxin)IBA
05/2012 - 06/2009
3AntigensIBA
09/2009 - 09/2005
3fludarabineIBA
09/2004 - 09/2002
2Phosphotransferases (Kinase)IBA
09/2014 - 01/2008
2Proteins (Proteins, Gene)IBA
10/2012 - 12/2010
2Antigen Receptors (Antigen Receptor)IBA
11/2010 - 09/2009
2Subcutaneous panniculitis-like T-cell lymphomaIBA
01/2010 - 08/2003
2Messenger RNA (mRNA)IBA
06/2007 - 02/2003
1decitabine (5-aza-2'-deoxycytidine)FDA Link
09/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2015
1ChromatinIBA
11/2013
1Toll-Like Receptor 2IBA
11/2013
1deficiency receptor 1 Interferon gammaIBA
08/2013
1interferon gamma receptorIBA
08/2013
1MicroRNAs (MicroRNA)IBA
06/2013
1Filgrastim (Neupogen)FDA Link
04/2013
1Janus KinasesIBA
02/2013
1Transcription Factors (Transcription Factor)IBA
02/2013
1Prednisolone (Predate)FDA LinkGeneric
01/2013
1Neutralizing AntibodiesIBA
05/2012
1CreatinineIBA
05/2012
1Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
05/2012
1Monoclonal AntibodiesIBA
05/2012
1Protein Kinases (Protein Kinase)IBA
03/2012
1Viral AntigensIBA
03/2012
17-hydroxystaurosporine (UCN 01)IBA
12/2011
1Cyclin EIBA
12/2011
1Indicators and Reagents (Reagents)IBA
09/2011
1B3(Fv)-PE38KDEL recombinant immunotoxinIBA
06/2011
1immunotoxin HA22IBA
06/2011
1NF-kappa B (NF-kB)IBA
01/2011
1InterleukinsIBA
01/2011
1interleukin-22 receptor (IL-22R)IBA
01/2011
1Fas Ligand Protein (Fas Ligand)IBA
01/2011
1AntibodiesIBA
01/2011
1TransaminasesIBA
12/2010
1CD19 AntigensIBA
11/2010
1AutoantibodiesIBA
10/2010
1Immunoglobulin A (IgA)IBA
10/2010
1Immunoglobulins (Immunoglobulin)IBA
10/2010
1VAP-cyclo protocolIBA
08/2010

Therapy/Procedure

19Drug Therapy (Chemotherapy)
07/2014 - 02/2002
2Transplantation (Transplant Recipients)
03/2012 - 03/2003
2Immunotherapy
03/2012 - 03/2008
2Aftercare (After-Treatment)
04/2010 - 10/2005
2Plasmapheresis
06/2009 - 09/2005
2Highly Active Antiretroviral Therapy (HAART)
07/2006 - 06/2003
1Radiotherapy
04/2013
1Molecular Targeted Therapy
11/2012
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2011